183
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Seroprevalence of Epstein-Barr virus and cytomegalovirus infections in Presidente Figueiredo, Amazonas, Brazil

, , ORCID Icon, ORCID Icon, , & ORCID Icon show all
 

ABSTRACT

Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections affect around 95% of the world’s population. In Brazil, there are few epidemiological reports related to EBV and CMV infection, especially in the western Amazon region. This study aimed to estimate the seroprevalence of EBV and CMV infection in individuals residents in Presidente Figueiredo, Amazonas, Brazil. Blood samples of 443 individuals were tested for the presence of anti-EBV and anti-CMV IgG antibodies through an enzyme-linked immunosorbent assay. EBV (95.9%; 95% CI: 0.94;0.98), CMV (96.8%; 95% CI: 0.95;0.98) and CMV/EBV (93%;95% CI: 0.91–0.95) coinfection were highly prevalent in the study population. Children (1 to 5 years) not attending school were less susceptible to EBV (OR 0.15; 95% CI: 0.05–0.52; p = 0.017) and CMV infections (OR 0.05; 95% CI: 0.02 − 0.17; p < 0.0001). Teenagers at high school showed increased susceptibility to CMV infection (OR 4.65; 95%CI: 1.43–15.08; p = .013) and EBV/CMV co-infection (OR 3.04; 95%CI: 1.44–6.45; p = 0.005). The seroprevalence of CMV and EBV infections were preeminent and tend to increase with age in the study population. Either attendance to a daycare facility or primary school before the age of 5 years may increase the susceptibility to EBV or CMV infection.

Acknowledgments

We thank the public health care units of Presidente Figueiredo for all support provided.

Disclosure of potential conflicts of interest

The authors declare no conflict of interest.

Additional information

Funding

This work was supported by the Coordination for Improvement of Higher Education Personnel-CAPES[PROCAD AMAZÔNIA 88881.200581/201801] and the National Council for Scientific and Technological Development - CNPq [404990/2013-4 and 448093/2014-6].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.